|

Role of Novel ILR in the Management of PVCs

RECRUITINGSponsored by Kansas City Heart Rhythm Research Foundation
Actively Recruiting
SponsorKansas City Heart Rhythm Research Foundation
Started2022-04-20
Est. completion2025-09
Eligibility
Age18 Years+
Locations6 sites
View on ClinicalTrials.gov →

NCT06060548

Summary

This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Patients \> 18 years of age
* Have a Medtronic LINQ II ILR
* Willing and able to give written informed consent

Exclusion Criteria:

* History of myocardial infarction
* Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronary angiography or Computed tomography angiography (CTA).
* History of cardiac arrest
* With existing implantable defibrillators
* Currently pregnant

Conditions3

Heart DiseaseMyocarditisPVC - Premature Ventricular Contraction

Locations6 sites

Kansas City Heart Rhythm Institute - Roe Clinic
Overland Park, Kansas, 66211
Donita Atkins816-651-1969Datkins@kchrf.com
Overland Park Regional Medical Center
Overland Park, Kansas, 66215
Donita Atkins
Centerpoint Medical Center Clinic
Independence, Missouri, 64057
Donita Atkins
Centerpoint Medical Center
Independence, Missouri, 64057
Donita Atkins
Research Medical Center Clinic
Kansas City, Missouri, 64032
Donita Atkins

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.